accountBiogen Idec Inc (BIIB.O) released surprisingly strong results from a clinical trial of its experimental multiple sclerosis drug BG-12 on Thursday, sending its shares up as much as 24 percent to an all-time... The Weston, Massachusetts-based biotechnology...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Biogen profit up; shares soar on drug data
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account